HoneyNaps' AI-Powered Sleep Diagnostic Software Designated as 73rd and 74th Innovative Medical Device by South Korea's Ministry of Food and Drug Safety
Tuesday, February 11, 2025
-- Simultaneous approval of AI solutions for diagnosing sleep disorders and
digital therapeutics for insomnia
-- Domestic certification secured following U.S. FDA approval
-- The only company to possess both AI algorithm development and hardware
technology
BOSTON, Feb. 3, 2025 /PRNewswire/ -- HoneyNaps, a leader in AI-based sleep data analysis, announced on December 16 that its AI-powered sleep disorder diagnostic software, "SOMNUM", and its second-generation digital therapeutic for insomnia, "SOMNUM Medella," have been designated as innovative medical devices by South Korea's Ministry of Food and Drug Safety (MFDS).
What Are Innovative Medical Devices?
Innovative medical devices are advanced technologies integrating high-intensity innovations in fields such as information technology, biotechnology, and robotics. These devices offer significantly enhanced safety and efficacy compared to conventional products. The MFDS designates innovative medical devices in areas like AI medical devices, digital therapeutics, and robotic surgical systems.
Products with this designation enjoy various benefits, such as expedited regulatory review processes and preferential participation in government-supported programs.
Details of SOMNUM and SOMNUM Medella
-- SOMNUM: Designated as the 73rd innovative medical device, SOMNUM is a
deep learning-based AI interpretation system that can analyze
multi-channel, time-series, and large-scale biometric data in real time.
Unlike traditional image-based systems, SOMNUM is built on explainable
AI (XAI) technology to enhance transparency and reliability.
-- SOMNUM Medella: Designated as the 74th innovative medical device, SOMNUM
Medella leverages HoneyNaps' proprietary contactless sleep data
monitoring system, "SOMNUM Scanning." This system combines objective
sleep analysis data with AI to create personalized treatment modules for
insomnia, maximizing patient compliance and treatment outcomes.
HoneyNaps' Unique Position
The MFDS has designated 74 innovative medical devices to date, with only seven companies receiving multiple designations. HoneyNaps stands out as the sole company with capabilities in both AI algorithm development and hardware technology.
Decades of Innovation Recognized
A representative from HoneyNaps commented, "For over a decade, we have focused on developing solutions spanning the entire spectrum of sleep data sensing, analysis, diagnosis, and treatment. We are thrilled that our technological innovations and efforts have been officially recognized through this designation."
Building on the U.S. FDA approval secured in 2023, the company aims to enhance its sleep data platform to better suit domestic medical needs, supporting healthcare professionals in delivering accurate diagnoses and effective treatments for sleep disorders.
For further information, please contact:
HoneyNaps USA, Inc.
Christine Kwon / Managing Director
Email: sleep@honeynaps.com
Address: #517, SPACES, 361 Newbury Street, Boston, MA, 02115
Website: www.honeynaps.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/honeynaps-ai-powered-sleep-diagnostic-software-designated-as-73rd-and-74th-innovative-medical-device-by-south-koreas-ministry-of-food-and-drug-safety-302366321.html
SOURCE HoneyNaps
|
|
|
|
|
 |
Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0 | Jan 22, 2026
|
|
RS now offers Phoenix Contact's pioneering new NearFi technology | Jan 22, 2026
|
|
Einride and IonQ Partnership Uses Quantum Computing to Optimize the Logistics of Electric and Autonomous Freight | Jan 22, 2026
|
|
SCAILIUM Debuts "AI Production Layer" to Overcome GPU Starvation and Slash AI Energy Waste | Jan 22, 2026
|
|
MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026 | Jan 22, 2026
|
|
Quantum Art Raises $100 Million in Series A Round to Drive Scalable, Multi-Core Quantum Computing | Jan 22, 2026
|
|
No Assembly Required: Barrett Distribution Centers Powers Maxwood Furniture's West Coast DTC Expansion | Jan 22, 2026
|
|
Hesai Recognized as the Only Lidar Company on Morgan Stanley's "Humanoid Tech 25" of Global Robotics Leaders | Jan 22, 2026
|
|
Fresco Raises EUR15m Series C to Power the Future of AI-Driven Cooking and the Connected Kitchen Ecosystem | Jan 22, 2026
|
|
LG ELECTRONICS EXPANDS ITS LIFESTYLE TV LINEUP WITH THE NEW ART-INSPIRED GALLERY TV | Jan 22, 2026
|
|
|
